3 results match your criteria: "Saskatoon Health Region and University of Saskatchewan[Affiliation]"
Can Assoc Radiol J
May 2018
College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada; Department of Medical Imaging, Saskatoon Health Region and University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Purpose: Not all endoscopically placed clips (endoclips) are magnetic resonance imaging (MRI) compatible. At many institutions, endoclip screening is part of the pre-MRI screening process. Our objective is to determine the contribution of each step of this endoclip screening protocol in determining a patient's endoclip status at our institution.
View Article and Find Full Text PDFAJR Am J Roentgenol
July 2017
1 University of Saskatchewan College of Medicine, Ste B526, Health Sciences Bldg, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.
Objective: Not all endoscopically placed clips are MRI compatible, so screening for endoscopic clips before MRI is recommended. The purpose of this study was to assess endoscopic clip screening practices at Canadian MRI centers, including number of centers that screen, specific screening methods, perceived safety of endoscopic clip models, and practices for dealing with confirmed gastrointestinal endoscopic clips.
Materials And Methods: A bilingual online survey was distributed to Canadian MRI centers to assess site demographics, endoscopic clip screening practices, safety considerations for different endoscopic clip models, protocols for dealing with patients with endoscopic clips, and the perceived value of screening.
Vet J
August 2014
Departments of Pathology and Laboratory Medicine, Microbiology and Immunology and Ophthalmology, Royal University Hospital, Saskatoon Health Region and University of Saskatchewan, Saskatoon, Saskatchewan S7N 0W8, Canada.
Pradofloxacin is a novel third-generation oral veterinary fluoroquinolone with activity against Gram-positive aerobic bacteria and anaerobes (lower minimum inhibitory concentrations in vitro). It also has activity against other bacterial species, including Bartonella henselae, Pasteurella multocida, Bordetella bronchiseptica, extra-intestinal Escherichia coli, and some mycobacterial species. This review focuses on the current knowledge of the mechanism of action, adverse effects, clinical applications, and pharmacokinetic/pharmacodynamic properties of pradofloxacin in cats.
View Article and Find Full Text PDF